Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Gastroenterology

Hepatobiliary/Pancreas

Statin use reduced hepatocellular carcinoma risk in patients with NAFLD

Clinical Gastroenterology and Hepatology | Feb 15, 2022 Hepatobiliary/Pancreas

Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: A randomized, open-label, phase 2 trial

The Lancet: Gastroenterology & Hepatology | Feb 12, 2022 Hepatobiliary/Pancreas

Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: A single-arm, open-label, phase 2 trial

The Lancet: Gastroenterology & Hepatology | Feb 12, 2022 Hepatobiliary/Pancreas

Risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis B patients receiving tenofovir disoproxil fumarate vs entecavir in the United States

Alimentary Pharmacology and Therapeutics | Feb 11, 2022 Hepatobiliary/Pancreas

Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysis

Gut | Feb 10, 2022 Hepatobiliary/Pancreas

Racial/ethnic disparities in hepatocellular carcinoma incidence and mortality rates in the United States, 1992-2018

Hepatology | Feb 09, 2022 Hepatobiliary/Pancreas

Sustained weight loss, weight cycling, and weight gain during adulthood and pancreatic cancer incidence in the Women’s Health Initiative (US)

American Journal of Epidemiology | Feb 03, 2022 Hepatobiliary/Pancreas

Frequent promoter hypermethylation and down regulation of BNIP3: An early event during gallbladder cancer progression

Digestive and Liver Diseases | Jan 29, 2022 Hepatobiliary/Pancreas

Lower risk of HCC in chronic hepatitis B patients treated with tenofovir vs entecavir

Journal of Gastroenterology and Hepatology | Jan 28, 2022 Hepatobiliary/Pancreas

Comparison of oncologic outcomes between open and laparoscopic distal pancreatectomy in pancreatic cancer

HPB | Jan 28, 2022 Hepatobiliary/Pancreas

« Prev 1 2 Next »

Statin use reduced hepatocellular carcinoma risk in patients with NAFLD

Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: A randomized, open-label, phase 2 trial

Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: A single-arm, open-label, phase 2 trial

Risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis B patients receiving tenofovir disoproxil fumarate vs entecavir in the United States

Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysis

Racial/ethnic disparities in hepatocellular carcinoma incidence and mortality rates in the United States, 1992-2018

Sustained weight loss, weight cycling, and weight gain during adulthood and pancreatic cancer incidence in the Women’s Health Initiative (US)

Frequent promoter hypermethylation and down regulation of BNIP3: An early event during gallbladder cancer progression

Lower risk of HCC in chronic hepatitis B patients treated with tenofovir vs entecavir

Comparison of oncologic outcomes between open and laparoscopic distal pancreatectomy in pancreatic cancer

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

These Popular Snacks Linked a Decline in Mental Health

Awareness for COPD: MCQ challenge

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Statin use reduced hepatocellular carcinoma risk in patients with NAFLD

Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: A randomized, open-label, phase 2 trial

Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: A single-arm, open-label, phase 2 trial

Risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis B patients receiving tenofovir disoproxil fumarate vs entecavir in the United States

Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysis

Racial/ethnic disparities in hepatocellular carcinoma incidence and mortality rates in the United States, 1992-2018

Sustained weight loss, weight cycling, and weight gain during adulthood and pancreatic cancer incidence in the Women’s Health Initiative (US)

Frequent promoter hypermethylation and down regulation of BNIP3: An early event during gallbladder cancer progression

Lower risk of HCC in chronic hepatitis B patients treated with tenofovir vs entecavir

Comparison of oncologic outcomes between open and laparoscopic distal pancreatectomy in pancreatic cancer

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

These Popular Snacks Linked a Decline in Mental Health

Awareness for COPD: MCQ challenge

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Select Specialty

Select Topic